Network biology: A promising approach for drug target identification against neurodevelopmental disorders
نویسندگان
چکیده
Biological entities are involved in complicated and complex connections; hence, discovering biological information using network biology ideas is critical. In the past few years, has emerged as an integrative systems-level approach for understanding interpreting these interactions. analysis one method reducing enormous data sets to clinically useful knowledge disease diagnosis, prognosis, treatment. The of can help us predict drug targets several diseases. identified through systems targeting essential pathways that contribute progression development disease. novel strategical system biology-assisted pharmacology coupled with computer-aided discovery (CADD) drugs fight multifactorial diseases efficiently. present review, we have summarized role application not only unfolding mechanism neurodevelopmental disorders but also identifying important like ADHD, Autism, Epilepsy, Intellectual Disability. Systems a promising aiming targeted precise treatment disorders.
منابع مشابه
Kinetoplast DNA: A Promising Drug Target for Treatment of Leishmaniasis
Leishmaniasis is a vector-borne zoonotic disease caused by various species of the genus Leishmania, (trypanosomatidae family) that is transmitted by phlebotomine sandflies. The disease can present in a range of clinical forms, including dermal lesions, metastasis mucocutaneous forms, and fatal visceral forms. In this non-systematic review, we aimed at introducing the role of kinetoplast DNA (kD...
متن کاملCNV biology in neurodevelopmental disorders
Copy number variants (CNVs), characterized in recent years by cutting-edge technology, add complexity to our knowledge of the human genome. CNVs contribute not only to human diversity but also to different kinds of diseases including neurodevelopmental delay, autism spectrum disorder and neuropsychiatric diseases. Interestingly, many pathogenic CNVs are shared among these diseases. Studies sugg...
متن کاملTAFI: a promising drug target?
420 Thrombin-activatable fibrinolysis inhibitor (TAFI) is a 60kDa metallocarboxypeptidase produced by the liver and present in plasma. Independently discovered by several groups, the enzyme is also known as plasma procarboxypeptidase B, procarboxypeptidase R, or procarboxypeptidase U (1-5). TAFI as nomenclature was introduced by Bajar et al. (5). TAFI is expressed as a latent precursor requirin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biocell
سال: 2023
ISSN: ['0327-9545', '1667-5746']
DOI: https://doi.org/10.32604/biocell.2023.029624